HALO Diagnostics Launches Subtle Medical's Suite of AI-powered Imaging Technologies for Better Patient Care

Subtle Medical | October 06, 2021

HALO Diagnostics (formerly Desert Medical Imaging), a leading medical imaging provider headquartered in Southern California, announced today a partnership with Subtle Medical, a healthcare technology company focused on AI-powered software solutions that enable faster, safer, and smarter medical imaging. HALO has implemented both SubtleMR™ and SubtlePET™ image enhancement software at multiple locations, leading to higher quality imaging and improved patient experience.


"With Subtle's technology, we now have the ability to restore image quality to standard of care when conducting shorter scan times for MRI and PET and lower dose PET exams. This combination allows us to better tailor scans to patient needs and improve workflow efficiency, patient experience, and patient safety.  The addition of Subtle Medical's technology to HALO Diagnostics furthers our commitment to precision focused, personalized healthcare."

MD, Chief Medical Officer at HALO Diagnostics


HALO Diagnostics is focused on saving and extending the quality of people's lives through the early detection of the leading causes of death with precision diagnostics. Combining leaders from the medical, scientific and high technology communities, HALO Diagnostics is a leader in the early detection of cancer's like Prostate and Breast in men and women.


"We could not be more pleased that Halo Diagnostics has adopted both SubtleMR and SubtlePET. Our unique technology not only supports a better patient experience from less time in the imaging suite, but also increased perceived safety. We look forward to a long partnership with Halo".

Chief Commercial Officer for Subtle Medical


Subtle Medical has an extensive product pipeline. The company's technologies utilize proprietary deep learning algorithms that integrate seamlessly with any OEM scanner to improve image quality from accelerated image acquisition without any alteration in the imaging specialists' workflow.  


About HALO
HALO Diagnostics (HALO Dx, Inc.) changes patient lives and outcomes through early detection of the leading causes of death with precision diagnostics. We accomplish this with a personalized diagnostic ensemble including advanced imaging, genomics, non-invasive liquid biomarkers, and community-based data at scale combined with deep learning algorithms. By optimizing all these solutions under the HALO Diagnostics platform, we provide rapid, precise, actionable results to enable life-changing treatments by physicians for their patients.


About Subtle Medical

Subtle Medical, Inc. is an innovative healthcare technology company with a suite of software solutions that use deep learning to increase the quality and efficiency of medical imaging. Subtle's software solutions are integrated at hospitals and imaging institutions worldwide.  It was named a CB Insights Top AI 100 and Digital Health 150 company in 2020 and is an Nvidia Inception Award Winner. 


Healthcare is no stranger to change. Neither is Washington. With a new administration in office, big adjustments are on the horizon. From the repeal and replacement of the Affordable Care Act to the rise of prescription drug costs, healthcare is a trending topic that’s certain to continue in D.C. President Trump and Congress have difficult decisions to make when it comes to healthcare. But, things can move pretty slowly on the Hill. So what changes can we actually expect to see in 2017?


Healthcare is no stranger to change. Neither is Washington. With a new administration in office, big adjustments are on the horizon. From the repeal and replacement of the Affordable Care Act to the rise of prescription drug costs, healthcare is a trending topic that’s certain to continue in D.C. President Trump and Congress have difficult decisions to make when it comes to healthcare. But, things can move pretty slowly on the Hill. So what changes can we actually expect to see in 2017?

Related News


Innovaccer Expands Global Footprint, Enters U.K. Market to Deliver Digital Transformation in Healthcare

Innovaccer Inc., | June 24, 2022

The Health Cloud firm, Innovaccer Inc., declared that as part of its growth into the UK healthcare industry, it will build an office in London. To support the legislative reforms of the NHS Health and Care Act 2022, Innovaccer offers data-driven technological solutions that can speed up innovation and digital transformation. The company's long-term expansion strategy and dedication to improving healthcare access, affordability, and quality around the world are both supported by the opening of the London office. The NHS recommended in 2019 that its design be changed in order to "improve coordination of services through the construction of Integrated Care Systems." The Health and Care Act of 2021 offered a framework to make it easier for the NHS, local governments, and other stakeholders to work together and promote the pandemic's recovery. The bill was enlarged by the Health and Care Act 2022, which included a wide variety of policy changes targeted at strengthening health and care services through improved integration of health and care and addressing growing health inequities. “The UK healthcare landscape is one of the best in the world. NHS England’s long-term plan clearly sets the direction for widespread digital services that can support and empower people to stay healthy and independent for longer. But they also acknowledge the challenge of identifying a technology provider that’s experienced with healthcare data. With Innovaccer’s data and analytics platform backed by a unified patient record, we can move towards addressing inequalities in health and population health, as well as wellbeing and the quality of services as part of the triple aim for NHS”. John Gurnett, General Manager, UK and Europe, Innovaccer More than 1,600 care settings have used Innovaccer's solutions. Over 39 million patients' records have been merged, helping over 96,000 caregivers work more cooperatively and saving more than £800 million as a result. Leading healthcare organizations have seen results like a 6.6 percent decrease in emergency room use, a 6.6 percent decrease in readmissions, and a 13 percent increase in referral success rate. “This is a milestone for the company in achieving our vision and for healthcare. By integrating data from multiple domains within the NHS and from local agencies, Innovaccer can help bridge the collaboration gap and provide analytics and actionable insights to meet the goals as set out by the Health and Care Act 2022—to improve the quality of care and reduce costs. Innovaccer’s capabilities in care coordination and population health will accelerate NHS’s vision of enabling people to live healthier and more independent lives through high-quality, seamless care”. Abhinav Shashank, co-founder and CEO of Innovac

Read More


Trueblue Designs the Future of Artificial Intelligence and Analytics for Healthcare

Trueblue | March 25, 2021

Trueblue, after having announced the integration of its Artificial Intelligence Relationship Management with Microsoft Dynamics 365 and Power Platform, officially launches on the market: AiDEA Smart Customer Engagement Suite. AiDEA is a modern AI-powered Omnichannel Customer Engagement suite. The solution's framework, represented by Artificial Intelligence, integrates and drives the operational and analytical functionalities based on Microsoft Dynamics 365 and Power Platform, for a holistic and integrated experience, intending to innovate the working model of Pharma & Life Science markets through simplifying omnichannel engagement through intuitive and conversational interactions. The transformation is driven by two fundamental components, the union of which has yet to materialize in the reference market: the concrete integration of Big Data in the context of Multichannel Management and the use of Artificial Intelligence functionalities and algorithms. The latter is an element that, from an IT standpoint, can no longer be delayed, because it is necessary to promote Customer Engagement processes to meet company goals on both a strategic and operational basis. These aspects require a significant change in organizational and tool approaches, as a generic Customer Relationship Management system is no longer sufficient. To provide precise indicators regarding one's customers in a fast, easy, and intuitive manner, it is important to incorporate precise Smart Omnichannel Customer Engagement solutions that are fully enabled in terms of Artificial Intelligence. After all, as part of this transition, pharmaceutical companies such as Angelini Pharma, Alfasigma, and others are heading in this direction with strength and determination, intending to innovate and obtain market results more quickly. "Artificial Intelligence represents a tremendous opportunity to increase our effectiveness and we want to provide this competitive advantage to our employee's thanks to AiDEA," said Pierluigi Antonelli, CEO of Angelini Pharma "After a long and thorough analysis, we identified Trueblue and Microsoft as the best partners to advance our Customer Engagement capabilities by delivering an innovative digital CRM solution that transforms strategy into action.” Trueblue, which has always been at the center of technological and digital innovation for the pharmaceutical industry, introduces with AiDEA a modern model in which Artificial Intelligence is the core and central force in the evolutionary process. "Through this integration, Trueblue will help companies in the industry accelerate their growth and find new ways to drive Digital Innovation through a wide range of solutions that will enable them to simplify the use of AI in their daily activities," said Marco Bonesini CEO of Trueblue “In today’s reality of accelerated digital transformation processes, pharma & life science companies rely on proactive solutions such as AIDEA, integrated with Dynamics 365 and Power Platform, to enable effective omnichannel strategies,” said Elena Bonfiglioli, Managing Director, Healthcare and Life Sciences, EMEA Regional Lead.

Read More


Fort HealthCare Partners with Ivenix to Provide Unprecedented Infusion Safety

Fort HealthCare | January 17, 2022

Ivenix, Inc., a medical technology company with the vision to eliminate infusion-related harm, today announced its successful go-live of the Ivenix Infusion System at Fort HealthCare, a nationally recognized hospital in Wisconsin. The implementation of the smart infusion pump is the first for Ivenix and Fort HealthCare, furthering their commitment to protect patients from medication errors while advancing clinical outcomes and operational efficiency. Fort HealthCare is an acute care facility and established technology leader, serving residents of Jefferson County. The hospital is nationally recognized by Leapfrog for its safety grade and by Fortune/IBM Watson Health as a top hospital. Fort HealthCare chose Ivenix for its unwavering commitment to medication safety, user-centered design, and advanced technology capabilities. “We are excited to bring smart infusion pumps into our hospital to further elevate the quality of care provided,” said Sheryl Krause, MS, RN, CEN, ACNS-BC, Emergency Services Director and Clinical Nurse Specialist at Fort Healthcare. “We have a strong team of nurses. Supporting them with new technology to optimize safety and efficiency helps everyone, especially the patients we care for.” The Ivenix Infusion System includes a large-volume infusion pump and infusion management software with unique capabilities new to the infusion therapy market. The pumps deployed at Fort HealthCare connect with the patient census to bring detailed information to elevate the nurse experience. “Ivenix is pleased to provide the latest in infusion safety technology to Fort Healthcare. Patient safety with zero harm is our number one goal. We are honored to be a part of the hospital’s efforts to modernize systems and elevate care.” Jorgen Hansen, CEO of Ivenix “Serving our community is priority one at Fort HealthCare,” said Mike Wallace, President and Chief Executive Officer. “We base our product choice decisions on what is safe, how it impacts our staff and patients, and the potential for integrating with other systems to optimize the investment. The Ivenix Infusion System delivers on all of those priorities.” About Fort HealthCare Fort HealthCare provides quality healthcare to the residents of an eight-community area and has the only hospital in Jefferson County. The hospital is a modern, fully accredited acute care facility with 49 beds and was recently recognized by Modern Healthcare as one of Wisconsin’s Best Places to Work in 2020. In addition to comprehensive inpatient services, Fort HealthCare offers ambulatory surgery and specialty clinics, a birthing center, cardiac rehabilitation, emergency services, including the Urgent Care Program for the after-hours treatment of minor illnesses and injuries, occupational medicine, and more. Fort Medical Group is a multi-specialty group practice with satellite clinics offering primary and specialty care in Fort Atkinson, Cambridge, Jefferson, Johnson Creek, Lake Mills, and Whitewater. Primary and specialty care physicians from UW Health, Dean Medical Center, and other organizations trust Fort Memorial Hospital to deliver the highest quality medical care to their patients. Read more about our various services. About Ivenix, Inc. Ivenix, located in North Andover, Mass., is a medical technology company with the vision of eliminating infusion-related errors by transforming infusion delivery. The Ivenix Infusion System includes a large-volume infusion pump, a portfolio of administration sets, and a suite of infusion management tools and analytics to inform care and advance clinical and operational efficiency. Infusion-related errors account for more than 50% of the 1.5 million adverse drug events reported annually to the US Food and Drug Administration (FDA). Infusion-related adverse drug events account for more than $2 billion in annual healthcare costs. Ivenix has a vision and commitment to improving infusion safety and medication delivery.

Read More